Category: Business

SAN BERNARDINO, CA / ACCESS Newswire / May 19, 2025 / Dateline Resources Limited (OTC:DTREF)(ASX:DTR) is pleased to update its shareholders on the strong financial position and ongoing progress of its flagship Colosseum Gold and Rare Earth Element (REE) Project in California. With a robust cash balance and recent capital inflows, the Company is fully funded to complete the Bankable Feasibility Study (BFS) for the Colosseum Gold Project, a significant milestone in unlocking the project’s value.

Key Highlights

Dateline Resources is well-positioned with current cash reserves of $1.95 million, which are expected to increase to $2.3 million upon receipt of part of the proceeds from the Udu Copper Project sale. The Company has raised approximately $1.1 million through recent warrant exercises, reflecting strong shareholder support. The BFS for the 1.1 million ounce Colosseum Gold Project is progressing on schedule, with metallurgical test work now underway. Additionally, planning for a dedicated REE drilling program at Colosseum is being advanced and guided by leading REE experts. The Company is also on track to uplist to the OTCQB Venture Market in Q3 2025, enhancing visibility for U.S. investors.

Financial Strength to Drive Colosseum Forward

Dateline’s cash reserves stand at $1.95 million, bolstered by $1.1 million raised from recent warrant exercises. An additional $350,000 is expected from the partial payment of the sale of the non-core Udu Copper Project in Fiji, bringing the total cash balance to approximately $2.3 million. These funds fully cover the costs of the Colosseum Gold Project’s BFS, ensuring the Company can advance this critical study without delay. The Company has also seen growing interest from warrant holders seeking to convert their holdings, signaling potential for additional organic funding. By monetizing non-core assets like the Udu Copper Project, Dateline is strategically focusing resources on its high-potential U.S. projects, particularly Colosseum.

“We are in a strong financial position to complete the Colosseum BFS, a pivotal step toward realizing the project’s full potential,” said Stephen Baghdadi, Managing Director. “With the support of our shareholders and disciplined capital management, we are well-equipped to deliver value for our investors.”

Colosseum Gold Project: BFS Progress

The BFS for the Colosseum Gold Project, which hosts a JORC-2012 compliant Mineral Resource of 1.1 million ounces of gold (27.1Mt @ 1.26g/t Au), commenced last month and remains on schedule. Key activities include metallurgical test work, with drill core shipped to Kappes, Cassiday & Associates in Nevada for analysis. Australian Mine Design & Development (AMDAD) is overseeing mine engineering, ensuring a comprehensive study that will guide the project’s development. The BFS is expected to be completed in December 2025

Rare Earth Elements: Expanding Colosseum’s Potential

In addition to its gold resources, Colosseum holds significant REE potential. Planning for a targeted REE drilling program is advancing, with program design led by renowned experts Dr. Anthony Mariano and Tony Mariano. The Company is finalizing drill targets and logistics and will soon commence the tender process for a drilling contractor. This program, announced on May 5, 2025, underscores Dateline’s commitment to maximizing the value of Colosseum’s diverse mineral assets.

OTCQB Uplisting to Broaden U.S. Investor Access

Dateline is on track to uplist to the OTCQB Venture Market in Q3 2025, a move designed to increase visibility and accessibility for U.S. investors. This uplisting will complement the Company’s ASX listing and support its growth strategy in the U.S. market, where Colosseum is strategically located in the Walker Lane Trend, less than 10km from the Mountain Rare Earth mine.

About Dateline Resources Limited

Dateline Resources Limited (OTC: DTREF, ASX: DTR) is an Australian publicly listed company focused on mining and exploration in North America. The Company owns 100% of the Colosseum Gold-REE Project in San Bernardino County, California, which hosts a 1.1 million ounce gold resource and significant REE potential.

For more information, visit www.datelineresources.com.au or follow us on X at https://twitter.com/Dateline_DTR.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of applicable securities laws. These statements relate to future events or future performance and include, but are not limited to, statements regarding the potential of the Colosseum Project, the expected benefits of the OTCQB listing, the company’s plans for future development, and the strategic importance of the project for U.S. critical minerals supply. Forward-looking statements are based on the company’s current expectations, estimates, and projections, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements. These risks and uncertainties include, but are not limited to: fluctuations in the prices of gold and rare earth elements; changes in regulatory requirements or permitting processes; geological or technical challenges in exploration and development; market conditions affecting the company’s ability to raise capital; environmental or social factors impacting operations; risks associated with the OTCQB listing process or trading on a new market; environmental and permitting risks associated with operating in a national preserve; uncertainty regarding the delineation of a mineable rare earth elements resource; risks related to the company’s ability to secure necessary funding for project development; and potential changes in government policies or priorities affecting the critical minerals sector. The company cautions readers not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company does not undertake any obligation to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

Competent Person Statement

The exploration information in this press release has been reviewed by Mr. Greg Hall, a Chartered Professional of the Australasian Institute of Mining and Metallurgy. Mr. Hall has sufficient experience relevant to the style of mineralization and deposit type to qualify as a Competent Person under the JORC Code. He consents to the inclusion of this information in the context in which it appears.

Contact Information:

Stephen Baghdadi
Managing Director
+61 2 9375 2353
info@datelineresources.com.au

Andrew Rowell
White Noise Communications
+61 400 466 226
andrew@whitenoisecomms.com

SOURCE: Dateline Resources Limited

View the original press release on ACCESS Newswire

YUMA, AZ / ACCESS Newswire / May 19, 2025 / Onvida Health, a leading provider of integrated care throughout Arizona, and Ambience Healthcare, the leading AI platform for clinical documentation, CDI, and coding, today announced the launch of a pilot program across multiple clinical sites.

Onvida Health clinicians across outpatient, inpatient, and emergency department settings will be piloting Ambience’s suite of AI applications to generate comprehensive and compliant documentation in real time-directly within Epic’s Electronic Health Record (EHR).

The pilot, launching in June 2025, reflects Onvida Health’s ongoing commitment to delivering the highest quality care in the region-while supporting clinicians with innovative technology to improve efficiency, reduce burnout, and increase time with patients.

With this technology, Onvida Health providers will spend less time on administrative work and more time with patients-while strengthening documentation integrity, supporting compliance, and improving financial accuracy.

“We are investing in the most advanced AI platform in healthcare because we believe the best patient care starts with supporting our clinicians,” said Marc Chasin, M.D., Senior Vice President and Chief Information Officer at Onvida Health. “Ambience will allow our clinicians to spend less time on paperwork and more time with their patients-while improving quality, accuracy and compliance.”

Ambience’s suite of AI applications includes:

• Scribing: The only AI medical scribe built to support the medicine, workflows, and coding and billing requirements of more than 100 specialties and subspecialties, including inpatient and emergency medicine

• CDI: A point-of-care CDI assistant that analyzes conversations and surfaces precise ICD-10 codes, CPT codes, and full audit trails for revenue cycle teams

• Patient Summaries: Comprehensive summaries for patients, their families, and caretakers

• Referrals: Clinically relevant and well-organized referral letters for primary care clinicians and specialists

Ambience’s AI platform helps clinicians design their agenda before a patient visit begins. Once the clinician is in the room with a patient, Ambience listens to the conversation. The technology then leverages all of the patient’s historical EHR data, as well as the recording of the visit, to automate documentation for the patient and clinician. This includes clinical notes, after-visit summaries, referral letters, and CPT and ICD-10 coding suggestions.

“By equipping our clinicians with Ambience’s AI technology, we’re ensuring that every patient receives more personalized attention, more thorough care, and a better overall experience,” said Kristina Diaz, M.D., President of Onvida Health Medical Group. “This partnership is about giving our patients and clinicians the time, focus, and quality they deserve-putting the human connection back at the center of every visit.”

Clinicians at leading health systems across North America leverage Ambience before, during, and after patient encounters. Ambience has been deployed at Cleveland Clinic, UCSF Health, St. Luke’s Health System, Houston Methodist, John Muir Health, Memorial Hermann Health System, and others.

“We are honored to partner with Onvida Health, an organization deeply committed to putting patients first, supporting their providers, and driving innovation,” said Mike Ng, CEO and Co-Founder of Ambience Healthcare. “Today, clinicians spend only about a quarter of their time on direct patient care – and together with Onvida Health, we are going to change that. By supporting every clinical encounter with Ambience’s AI technology, we’re helping clinicians reclaim their time, enhance compliance and accuracy, and refocus healthcare around what matters most: the patient.”

About Onvida Health

Onvida Health is a not-for-profit hospital system with 430 inpatient beds, 45 outpatient clinics and a free-standing Emergency Department. The Onvida Health team includes 495 providers representing 52 specialties, 4000 employees and hundreds of volunteers who work closely together to create a welcoming, caring and compassionate environment for patients and their families. Onvida Health is dedicated to building a healthier tomorrow for Yuma County residents and the surrounding southwestern Arizona communities.

About Ambience Healthcare
Ambience Healthcare’s mission is to supercharge healthcare providers with breakthrough generative AI technology. Ambience’s products are currently leveraged by leading provider organizations and health systems across North America to reduce documentation burden, alleviate provider burnout, and improve care quality. Founded in 2020 by Mike Ng and Nikhil Buduma, Ambience is headquartered in San Francisco, California, and backed by Andreessen Horowitz, OpenAI Startup Fund, Human Capital, Kleiner Perkins, Martin Ventures, AIX Ventures, AirTree Ventures, John Doerr, Jeff Dean, Richard Socher, Pieter Abbeel, Anne Wojcicki, Eren Bali, Jay Desai, Nish Bhat, Matt Mochary, and others. To learn more, visit ambiencehealthcare.com.

For more information, press only:

Karina Stabile
Aria Marketing for Ambience Healthcare
kstabile@ariamarketing.com
516-317-5835

Jenn Lotz Williams
(504) 376-3253
Jwilliams4@onvidahealth.org

SOURCE: Ambience

View the original press release on ACCESS Newswire

IRVINE, CA / ACCESS Newswire / May 19, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) (“enVVeno” or the “Company”), a company setting new standards of care for the treatment of deep venous disease, announced the appointment of Jennifer Bright as Chief Financial Officer, effective today, May 19, 2025. Ms. Bright brings more than 25 years of financial and strategic leadership experience built across several commercial-stage medical device and pharmaceutical companies including Biolase, Spectrum Pharmaceuticals, Apria Healthcare, Smile Brands, and Teleflex Medical, as well as technical accounting and auditing experience at PricewaterhouseCoopers LLP.

“Jennifer brings a wealth of commercial experience to the CFO role, which we believe will be instrumental as we transition from a development-stage company to a commercial entity,” said Robert Berman, enVVeno Medical’s Chief Executive Officer. “In addition to overseeing our financial strategy and operations, Jennifer will play a critical role in strengthening our financial infrastructure, supporting our commercialization efforts for VenoValve, and expanding our relationships with institutional investors and analysts. Her experience navigating growth and change will be a valuable asset as we enter this next phase of the Company’s evolution.”

Ms. Bright is a Certified Public Accountant and received a B.A. degree in Business Administration, Accounting, from the University of Washington. She succeeds Craig Glynn, who will continue to be available to the Company in an advisory capacity.

The Company is currently developing two devices for the treatment of deep venous CVI, a potential first-in-class surgical replacement venous valve called the VenoValve®, and a non-surgical replacement venous valve called enVVe®. The Company estimates that there are approximately 2.5 million potential new patients each year in the U.S. that could be candidates for replacement venous valves, including approximately 1.5 million with active venous ulcers. The Company has submitted a pre-market authorization (PMA) application for the VenoValve to the FDA, with a decision anticipated in the second half of 2025. In the third quarter of 2025, the Company expects to file an Investigational Device Exemption (IDE) seeking authorization from the FDA to begin enVVe pivotal trial.

About CVI
Severe, deep venous Chronic Venous Insufficiency (CVI) is a debilitating disease that is most often caused by blood clots (deep vein thromboses or DVTs) in the deep veins of the leg. When valves inside of the veins of the leg fail, blood flows in the wrong direction and pools in the lower leg, causing pressure within the veins of the leg to increase (venous hypertension). Symptoms of severe CVI include leg swelling, pain, edema, and in the most severe cases, recurrent open sores known as venous ulcers. The disease can severely impact everyday functions such as sleeping, bathing, dressing, and walking, and is known to result in high rates of depression and anxiety. There are currently no effective treatments for severe CVI of the deep vein system caused by valvular incompetence. Estimates indicate that CVI costs the U.S. healthcare system in excess of $4 billion each year.

About enVVeno Medical Corporation
enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device Company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of deep venous disease. The Company’s lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous CVI. The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe®. CVI occurs when valves inside of the veins of the leg become damaged, resulting in the backwards flow of blood (reflux), blood pooling in the lower leg, increased pressure in the veins of the leg (venous hypertension) and in severe cases, venous ulcers that are difficult to heal and become chronic. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The Company has submitted a pre-market authorization (PMA) application for the VenoValve to the FDA, with a decision anticipated in the second half of 2025 and is currently performing the final testing necessary to seek approval from the FDA for the enVVe pivotal trial.

Cautionary Note on Forward-Looking Statements
This press release and any statements of stockholders, directors, employees, representatives and partners of enVVeno Medical Corporation (the “Company”) related thereto contain, or may contain, among other things, certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve significant risks and uncertainties. Such statements may include, without limitation, statements identified by words such as “projects,” “may,” “will,” “could,” “would,” “should,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “potential” or similar expressions. These statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties, including those detailed in the Company’s filings with the Securities and Exchange Commission. Actual results and timing may differ significantly from those set forth or implied in the forward-looking statements. Forward-looking statements involve certain risks and uncertainties that are subject to change based on various factors (many of which are beyond the Company’s control). The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future presentations or otherwise, except as required by applicable law.

###

INVESTOR CONTACT:
Jenene Thomas, JTC Team, LLC
NVNO@jtcir.com
(908) 824-0775

MEDIA CONTACT:
Glenn Silver, FINN Partners
Glenn.Silver@finnpartners.com
(973) 818-8198

SOURCE: enVVeno Medical Corporation

View the original press release on ACCESS Newswire

BRIDGEWATER, NJ / ACCESS Newswire / May 19, 2025 / Tharimmune, Inc. (Nasdaq:THAR), a clinical-stage biopharmaceutical company focused on developing innovative therapeutics, today announced the appointment of James Gordon Liddy (CDR US Navy SEAL (Ret)) as a strategic advisor. Mr. Liddy, an internationally recognized expert on counterterrorism and critical infrastructure protection, will provide invaluable guidance as Tharimmune advances the development of TH104, its lead program for temporary prophylaxis against respiratory and/or central nervous system depression in military personnel and chemical incident responders exposed to high-potency opioids, including potential weaponized agents like fentanyl.

Mr. Liddy brings a distinguished career and unparalleled expertise in national security and preparedness to Tharimmune. As the Senior Advisor to the Director for Strategy, Policy and Initiatives for the Office of the Assistant Secretary of Defense for Special Operations and Low Intensity Conflict, and previously the Chief of Plans and Policy for the United States Special Operations Command’s Washington Office, he played a pivotal role in designing and coordinating policy, operational plans, and strategic initiatives for the Global War on Terrorism. His experience as a member of a highly classified national security program further underscores his deep understanding of the threats facing the nation.

Notably, CDR Liddy’s tenure as the Combating Terrorism and Special Operations Officer for the Chief of Naval Operations saw him as the principal architect for the Navy’s Anti-Terrorism Force Protection Plan and the leader of the Navy’s elite Antiterrorism Assessment Team (Red Cell). He also spearheaded the creation of DoD’s Anti-terrorism and Force Protection Plan DoD Directive 20012.H, demonstrating his capability to develop and implement critical protective measures at the highest levels of government.

Tharimmune recently announced positive feedback from the U.S. Food and Drug Administration (FDA) regarding the advancement of TH104 for the prophylaxis indication against ultrapotent opioid exposure. The FDA indicated that no additional clinical trials appear to be necessary prior to a 505(b)(2) New Drug Application (NDA) submission, allowing Tharimmune to leverage existing data and focus on this critical unmet need for military personnel and first responders.

“We are honored to welcome James Gordon Liddy to our team as a strategic advisor,” said Vincent LoPriore, Executive Chairman of Tharimmune. “His extensive background in counter-terrorism, critical infrastructure protection, and the development of national security strategies aligns perfectly with our mission to advance TH104 as a crucial medical countermeasure against the threat of weaponized opioids. Mr. Liddy’s insights and guidance will be invaluable as we work to bring this potentially life-saving prophylaxis to those on the front lines.”

Mr. Liddy’s deep expertise in threat assessment, preparedness, and response planning will provide Tharimmune with unique strategic perspectives as the company navigates the development and potential deployment of TH104 within national security frameworks. His understanding of the operational environments faced by military personnel and chemical incident responders, as well as the critical need for effective countermeasures, will be instrumental in shaping Tharimmune’s approach.

“I am impressed with Tharimmune’s commitment to addressing the serious national security threat posed by high-potency opioids, including weaponized fentanyl,” said James Gordon Liddy. “The potential of TH104 to provide a temporary prophylactic solution is significant. I look forward to contributing my experience to help guide Tharimmune’s strategy and accelerate the availability of this important medical countermeasure to protect our servicemen and women and first responders.”

Mr. Liddy holds a Masters Degree from the John Hopkins University School of Advanced International Studies (SAIS) and has completed the Information Operations Curriculum at the National Defense University. He is also a Doctoral student in Complex Emergency and Disaster Management at Tulane University, with a Graduate CBRNE sub-specialty curriculum from the Uniformed Services Medical School, Bethesda MD. He is also the co-author of the New York Times bestseller, FIGHT BACK, Tackling Terrorism Liddy Style.

About Tharimmune, Inc.

Tharimmune is a clinical-stage biotechnology company developing a diverse portfolio of therapeutic candidates in immunology, inflammation and oncology. Its lead clinical asset, TH104, is being developed for a specific indication via a 505(b)2 pathway for respiratory and/or nervous system depression in military personnel and chemical incident responders who may encounter environments contaminated with high-potency opioids. The expanded pipeline includes other indications for TH104, such as chronic pruritus in primary biliary cholangitis and TH023, a new approach to treating autoimmune diseases along with an early-stage multispecific biologic platform targeting unique epitopes against multiple solid tumors through its proprietary EpiClick^™ Technology. The Company has a license agreement with OmniAb, Inc. to access their antibody discovery technology for targeting specified disease markers. Tharimmune continues to position itself as a leader in patient-centered innovation while working to deliver long-term value for shareholders. For more information, visit: www.tharimmune.com.

Forward Looking Statements

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, contained in this press release, including statements regarding the timing and design of Tharimmune’s future Phase 2 trial, Tharimmune’s strategy, future operations, future financial position, projected costs, prospects, plans and objectives of management, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “depends,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “target,” “should,” “will,” “would,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The Company may not actually achieve the plans, intentions, or expectations disclosed in these forward-looking statements, and you should not place undue reliance on these forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in these forward-looking statements. Factors that may cause such differences, include, but are not limited to, those discussed under Risk Factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2024 and other periodic reports filed by the Company from time to time with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent the Company’s views as of the date of this release. Subsequent events and developments may cause the Company’s views to change; however, the Company does not undertake and specifically disclaims any obligation to update or revise any forward-looking statements to reflect new information, future events or circumstances or to reflect the occurrences of unanticipated events, except as may be required by applicable law. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of this release.

Contacts

Tharimmune, Inc.
ir@tharimmune.com

Alliance Advisors IR
Tirth T. Patel
tpatel@allianceadvisors.com
212-201-6614

SOURCE: Tharimmune Inc.

View the original press release on ACCESS Newswire

Company reports quarterly revenue of $1.4 million; net loss and earnings per diluted Share of $6.6 million and $1.74

Quarterly adjusted EBITDA loss of $2.5 million reflects 29% YOY improvement

Stockholders’ equity was $13.8 million at quarter end

Increases 2025 pro forma revenue guidance to more than $75 million based on strong first quarter across TRNR, Sportstech and Wattbike

AUSTIN, TEXAS / ACCESS Newswire / May 19, 2025 / Interactive Strength Inc. (Nasdaq:TRNR) (“TRNR” or the “Company”), maker of innovative specialty fitness equipment under the CLMBR and FORME brands and pending acquirer of Sportstech and Wattbike, today announced its financial results for the first quarter of 2025.

The Company reported revenue of $1.4 million, a nearly 4x increase from the prior-year period. Net loss for the quarter was $6.6 million, or $1.74 per diluted share, compared with a net loss of $11.4 million and $2,681.82 per share in the same period last year. These figures do not include the pending acquisitions of Sportstech and Wattbike.

Adjusted EBITDA, a non-GAAP financial measure, was a loss of $2.5 million, reflecting improved operational efficiency. Stockholders’ equity increased to $13.8 million, up from $7.1 million at year-end 2024, strengthening compliance with a key Nasdaq continued-listing requirement.

As a result of strong Q1 performance across TRNR and the pending acquisitions of Sportstech, and Wattbike – which all together generated more than $20 million in pro forma revenue during the first quarter – the Company is raising its full-year 2025 pro forma revenue guidance to more than $75 million, a greater than 15% increase from the April guidance of $65 million.

Trent Ward, CEO and Co-Founder of TRNR, said: “Our acquisition activity in the past few months and our improved shareholder’s equity are expected to result in a transformational year. While our Sportstech and Wattbike deals are not yet closed, and therefore not reflected in our reported financials yet, we are operating as one group and our pro forma Q1 shows more than $20M in revenues when including those acquisitions. As a result, we are increasing our 2025 pro forma revenue guidance to more than $75M and we expect that we will generate positive adjusted EBITDA in Q4 given that we would have been close to this milestone on a pro forma basis in Q1. We’re focused on closing the transactions in the near-term and integrating operations to drive increased growth and synergy.”

For more commentary, information and details of TRNR’s strategy, as well as to sign up for direct updates, see the Company’s investor website, latest FAQs and required filings with the US Securities & Exchange Commission (SEC).

TRNR Investor Contact
ir@interactivestrength.com

About Interactive Strength Inc.:
Interactive Strength Inc. produces innovative specialty fitness equipment and digital fitness services under two main brands: 1) CLMBR and 2) FORME. Interactive Strength Inc. is listed on NASDAQ (symbol: TRNR).

CLMBR is a vertical climbing machine that offers an efficient and effective full-body strength and cardio workout. CLMBR’s design is compact and easy to move – making it perfect for commercial or in-home use. With its low impact and ergonomic movement, CLMBR is safe for most ages and levels of ability and can be found at gyms and fitness studios, hotels, and physical therapy facilities, as well as available for consumers at home. www.clmbr.com.

FORME is a digital fitness platform that combines premium smart gyms with live virtual personal training and coaching to deliver an immersive experience and better outcomes for both consumers and trainers. FORME delivers an immersive and dynamic fitness experience through two connected hardware products: 1) The FORME Studio Lift (fitness mirror and cable-based digital resistance) and 2) The FORME Studio (fitness mirror). In addition to the company’s connected fitness hardware products, FORME offers expert personal training and health coaching in different formats and price points through Video On-Demand, Custom Training, and Live 1:1 virtual personal training. www.formelife.com.

• Adjusted EBITDA is widely used by investors and securities analysts to measure a company’s operating performance without regard to items such as stock-based compensation expense, depreciation and amortization expense, other expense (income), net, and provision for income taxes that can vary substantially from company to company depending upon their financing, capital structures, and the method by which assets were acquired;

• Our management uses Adjusted EBITDA in conjunction with financial measures prepared in accordance with GAAP for planning purposes, including the preparation of our annual operating budget, as a measure of our core operating results and the effectiveness of our business strategy, and in evaluating our financial performance; and

• Adjusted EBITDA provides consistency and comparability with our past financial performance, facilitate period-to-period comparisons of our core operating results, and may also facilitate comparisons with other peer companies, many of which use similar non-GAAP financial measures to supplement their GAAP results.

• Although depreciation and amortization expense are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and Adjusted EBITDA does not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements;

• Adjusted EBITDA excludes stock-based compensation expense, which has recently been, and will continue to be for the foreseeable future, a significant recurring expense for our business and an important part of our compensation strategy;

• Adjusted EBITDA does not reflect: (1) changes in, or cash requirements for, our working capital needs; (2) interest expense, or the cash requirements necessary to service interest or principal payments on our debt, which reduces cash available to us; or (3) tax payments that may represent a reduction in cash available to us;

• Adjusted EBITDA does not reflect impairment charges for fixed assets and capitalized content, and gains (losses) on disposals for fixed assets;

• Adjusted EBITDA does not reflect (gains) losses associated with debt extinguishments.

• Adjusted EBITDA does not reflect losses associated with vendor settlements.

• Adjusted EBITDA does not reflect transaction related expenses for CLMBR acquisition and pending acquisitions of Wattbike and Sportstech.

• Adjusted EBITDA does not reflect non cash fair value gains (losses) on convertible notes, derivatives, warrants and unrealized currency gains (losses).

Forward Looking Statements:
This press release includes certain statements that are “forward-looking statements” for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements do not relate strictly to historical or current facts and reflect management’s assumptions, views, plans, objectives and projections about the future. Forward-looking statements generally are accompanied by words such as “believe”, “project”, “expect”, “anticipate”, “estimate”, “intend”, “strategy”, “future”, “opportunity”, “plan”, “may”, “should”, “will”, “would”, “will be”, “will continue”, “will likely result” or similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding the possibility of acquiring future businesses or completing the referenced pending transactions in a timely manner or at all, the financial performance of those acquisitions and the resulting guidance of having more than $75m of pro forma revenue in 2025, achieving profitability by Q4, and the financial performance of the acquisition targets which have not been audited or reviewed by a PCAOB auditor and could vary materially (a) once that audit or review work is completed and such financials are included in the Company’s reported financials and (b) due to the effect of the exchange rates of foreign currencies which can be volatile. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of the Company. Risks and uncertainties include but are not limited to: demand for our products and the products of the acquisition targets if the acquisitions are completed (collectively, the “Products”); competition, including technological advances made by and new products released by our competitors and the competitors of the acquisition targets; our ability to accurately forecast consumer demand for our Products and adequately maintain our inventory; and our reliance on a limited number of suppliers and distributors for our Products. A further list and descriptions of these risks, uncertainties and other factors can be found in filings with the Securities and Exchange Commission. To the extent permitted under applicable law, the Company assumes no obligation to update any forward-looking statements.

# # #

SOURCE: Interactive Strength Inc.

View the original press release on ACCESS Newswire

With Faster IRS Processing, Taxpayers May Face Quicker Enforcement – Clear Start Tax Urges Immediate Action to Avoid Penalties

IRVINE, CA / ACCESS Newswire / May 19, 2025 / The IRS has made significant progress in clearing its backlog of unprocessed returns and collection cases, but that may not be good news for taxpayers who are behind. According to Clear Start Tax, a nationally recognized tax resolution firm, fewer delays mean faster enforcement, and taxpayers who previously benefited from slow processing may now find themselves facing levies, liens, and garnishments with little warning.

“The IRS has caught up – and they’re coming faster,” said the Head of Client Solutions at Clear Start Tax. “If you owe back taxes or haven’t filed, now is the time to act. The window to resolve your situation before enforcement begins is closing.”

Faster Processing Means Quicker Consequences

In the wake of increased funding and technology upgrades, the IRS is moving more aggressively to enforce unpaid tax balances. Taxpayers who previously went months-or even years-without contact are now receiving notices and enforcement actions much more quickly.

Clear Start Tax warns that this acceleration puts taxpayers at higher risk of:

• Wage garnishments that reduce take-home pay without court involvement

• Bank levies that freeze and drain checking or savings accounts

• Tax liens that damage credit scores and block financial opportunities

• Penalty and interest accumulation that rapidly increases the total debt

Why Waiting Is No Longer a Safe Option

In previous years, delays within the IRS backlog often gave taxpayers additional time before enforcement actions began. Now that processing has accelerated, that grace period has effectively disappeared. Clear Start Tax notes that once a case enters the IRS collections system, enforcement is frequently initiated through automated processes – making a timely response more critical than ever.

“Enforcement is moving faster than many taxpayers expect,” said the Head of Client Solutions at Clear Start Tax. “Once the IRS begins its process, things can escalate quickly without warning.”

The Clear Start Tax Approach: Strategic Support Before the IRS Acts

Clear Start Tax takes a proactive, hands-on approach to resolution, not just reacting to IRS enforcement, but helping clients stay ahead of it. Every case begins with a full financial analysis to understand the taxpayer’s position and identify the most effective path forward.

The team then develops a personalized plan that may include:

• Submitting an Offer in Compromise to settle the debt for less than what’s owed

• Setting up a structured Installment Agreement with affordable monthly payments

• Requesting Currently Not Collectible status for those experiencing financial hardship

• Engaging directly with IRS agents to halt garnishments, release levies, or delay further action

Beyond resolving the immediate issue, Clear Start Tax works with clients to ensure they remain compliant going forward, so future risks are minimized and financial stability is restored.

About Clear Start Tax

Clear Start Tax is a full-service tax liability resolution firm that serves taxpayers throughout the United States. The company specializes in assisting individuals and businesses with a wide range of IRS and state tax issues, including back taxes, wage garnishment relief, IRS appeals, and offers in compromise. Clear Start Tax helps taxpayers apply for the IRS Fresh Start Program, providing expert guidance in tax resolution. Fully accredited and A+ rated by the Better Business Bureau, the firm’s unique approach and commitment to long-term client success distinguish it as a leader in the tax resolution industry.

Need Help With Back Taxes?

Click the link below:
https://clearstarttax.com/qualifytoday/

Contact Information

Clear Start Tax
Corporate Communications Department
seo@clearstarttax.com
(949) 535-1627

SOURCE: Clear Start Tax

View the original press release on ACCESS Newswire

BARRIE, ON / ACCESS Newswire / May 19, 2025 / Consumer Choice Award (CCA) is proud to announce that Home Care Assistance of Barrie has been named the 2025 Consumer Choice Award Winner in the Home Healthcare Services category. This recognition honours the organization’s dedication to personalized, compassionate care and its continued commitment to supporting families and their loved ones across the region.

Home Care Assistance of Barrie is a trusted name in senior care and home healthcare solutions, helping individuals live safely, comfortably, and independently at home. Whether clients are recovering from surgery, managing a chronic condition, or coping with age-related changes, the team provides customized support tailored to each person’s unique needs and schedule.

Founded on the belief that every senior deserves not only care-but also dignity, joy, and a sense of purpose-Home Care Assistance of Barrie was established to fill a vital need in the community. The organization offers a holistic approach to caregiving that prioritizes emotional and physical well-being through structured programs, meaningful interaction, and highly personalized service.

“We are honoured to receive this recognition from Consumer Choice Award,” said the Home Care Assistance of Barrie team. “This award reflects our mission to provide the highest standard of care and to support families with the compassion, professionalism, and trust they deserve.”

What sets Home Care Assistance apart is its Balanced Care Method™, an evidence-based approach to aging well that promotes healthy nutrition, physical activity, mental stimulation, social engagement, and purpose. Each care plan is carefully tailored, not only to support daily needs, but also to enhance quality of life.

The organization’s services cover a wide spectrum of care needs, including support for those living with Alzheimer’s, dementia, Parkinson’s, stroke recovery, disabilities, and mobility limitations. From part-time companionship to full-time in-home care, Home Care Assistance of Barrie is equipped to meet a variety of health and wellness goals.

Services include:

• Personalized care planning and flexible scheduling

• Alzheimer’s and dementia care

• Post-hospitalization and chronic condition support

• Assistance with daily living and mobility

• Companionship, respite, and wellness monitoring

• Live-in and 24/7 care options

In addition to its caregivers, the organization’s care team includes Client Care Managers who maintain direct relationships with clients and their families. Regular check-ins, care evaluations, and ongoing communication ensure that every client receives seamless support at all stages of care.

All caregivers undergo a rigorous selection process, background checks, and specialized training, ensuring peace of mind for families. Home Care Assistance of Barrie is known for its caregiver continuity, which helps build trusting, long-lasting relationships that benefit both clients and families.

Beyond one-on-one care, the organization is also a strong community advocate-offering educational seminars, wellness workshops, and caregiver support programs. Their outreach and engagement efforts reflect a deep-rooted mission to elevate the standard of aging for seniors throughout Barrie.

With a strong reputation built on trust, professionalism, and results, the organization continues to serve as a valuable partner to individuals and families throughout Barrie and surrounding communities. Online testimonials and local referrals consistently reinforce Home Care Assistance’s position as a go-to provider for high-quality home care in Ontario.

To learn more about Home Care Assistance of Barrie or to book a complimentary care consultation, CLICK HERE or visit www.homecareassistancebarrie.ca.

About Consumer Choice Award:
Consumer Choice Award has been recognizing and promoting business excellence in North America since 1987. Its rigorous selection process ensures that only the most outstanding service providers in each category earn this prestigious recognition. Visit www.ccaward.com to learn more.

Contact Information:
Sumi Saleh
Communications Manager
ssaleh@ccaward.com

SOURCE: Consumer Choice Award

View the original press release on ACCESS Newswire

MONTREAL, QC / ACCESS Newswire / May 19, 2025 / Consumer Choice Award is pleased to announce the 2025 award recipients in Montreal and surrounding regions. These businesses have been meticulously selected through independent market research, reflecting their commitment to excellence and unparalleled service in their city. Consumer Choice Award celebrates those who have consistently set the benchmark for quality and customer satisfaction. Congratulations to the 2025 Montreal and Regions Consumer Choice Award Winners.

GREATER MONTREAL’S AWARD RECIPIENTS

A-Extermination Extermination & Pest Management www.a-extermination.com		Amora Dating Agency www.amora-qc.com/en
Bell Aluminium Inc. Stairs & Railings www.bellaluminium.com		Boni Enseignes Signs www.bonienseignes.com
BonPrix Électroménagers Household appliances sales www.bonprixelectromenagers.com		Boutique Mariclod Wedding and Prom Dresses www.boutiquemariclod.com
Clinique de Chirurgie Plastique de Montréal Plastic Surgery Clinic www.ccpmtl.com		Clinique de Greffe de Cheveux Bédard Hair Restoration www.cliniquebedard.com
Clinique Laflamme Medical Aesthetic Clinic www.cliniquelaflamme.com		Cliniques Médicales Lacroix Private Medical Clinic www.cliniquesmedicaleslacroix.com/en/
Cuisimax Inc. Kitchen Cabinets www.cuisimax.com/en/		Déménagement le Clan Panneton Moving Services www.demenagementleclanpanneton.com
Éco Dépot de Carreaux Céramique 440 Inc. Ceramic and Porcelain Tiles www.eco-depot.ca		ÉquipeNutrition Nutritionist/Dietitian www.equipenutrition.ca
H2Pro Pool Maintenance and Repair www.piscineh2pro.com		Lambert Avocats Personal Injury www.lambertavocats.ca
Le Groupe Adèle Inc. Housekeeping Services www.adeleplus.com		Le Groupe Imperial Duct Cleaning www.nettoyageimperial.ca
Les Goudrons du Québec Inc. Foundation Waterproofing www.lesgoudronsduquebec.com		Les Produits des Fenêtres Sol-R Inc. Blinds and Window Treatments www.sol-r.ca
Les Résidences Soleil Private Senior Residences www.residencessoleil.ca		Lexus Laval Car Dealership – Lexus www.lexuslaval.ca/en
Produits Alimentaires Italiens New Milano Inc. Butcher and Deli www.newmilano.com		Service 2000 Appliance Repair & Maintenance www.service2000.ca
SoumissionRénovation.ca General Contractor www.renoquotes.com/en		Top Marquage Parking Lot Line Painting and Floor Marking www.topmarquage.ca
VIP Investigation Inc. Private Investigator www.spyvip.com/en		Vitrerie des Experts Glass and Mirrors – Sales and Services www.glassexperts.com

———

PROVINCE DE QUÉBEC’S AWARD RECIPIENTS

Benjamin Moore Painting (Brand) www.benjaminmoore.ca

Learn more about 2025 Greater Montréal Consumer Choice Award Winners HERE.

———

MONTRÉAL ISLAND’S AWARD RECIPIENTS

Amika – Aide Et Soins À Domicile Home Care Services www.soinsamika.com		C.M. Montreal Inc. Heavy Vehicle Maintenance www.cmmontreal.com
Centre D’Impôt Le Carrefour Accounting www.lecarrefourimpot.ca		Clinique Vétérinaire Rue Ontario Veterinarians www.veterinairerueontario.com
Clôtures Frontenac Fence Manufacturer and Installer www.cloturesfrontenac.com		Création Animaux RB Pet Crematorium and Funeral Home www.cremationanimauxrb.ca
Cuisines & Comptoirs Montréal Kitchen Cabinets www.cuisinesetcomptoirsmontreal.ca		cVERT Lawn Care www.cvert.ca
Déménagement Total Moving Company www.demenagement-total.ca		Dr. Normand Bach, Orthodontiste Orthodontist www.orthodontistemontreal.com
Electrika Inc. Electrical Contractor www.electrika.ca		Escaliers Multi Design Flooring and Staircases www.escaliersmultidesign.com
Gestion Samurai Property Management www.gestionsamurai.com		Git Portes Et Fenêtres En Aluminium Doors and Windows www.gitportesfenetres.ca
Hot & Cold Inc. Heating and Air Conditioning Contractor www.hotncold.ca		Institut Capillaire Louise Morisset Hair Restoration and Trichology www.institutlouisemorisset.com
Irriglobe Irrigation Systems www.irriglobe.com		J Gérard Fortin & Associés Inc. Auto, Home, and Business Insurance www.jgfortin.com
Jean Fortin Réorganisation Financière Licensed Insolvency Trustees www.jeanfortin.com		Jolois Consultants Informatiques IT Consultants www.jolois.com
Les Fondations Nouvelle Génération Inc. Foundation Waterproofing and Repair www.lesfondationsnouvellegeneration.com		Mandyz Salon Hair Salon www.mandyzsalon.com
Martin Dumont Équipe Immobilière Residential Real Estate Brokerage www.martin-dumont.ca		Megafun Mobile DJs and Entertainment www.megafunanimation.com
Montréal Pro Cleaning Inc. Residential and Commercial Cleaning Services www.montrealprocleaning.com		Peintres LGL Inc. Painting Contractor www.peintreslgl.com
Protectzone Alarm Systems www.protectzone.ca		Remorquage Top Speed Towing Services www.remorquage-topspeed.ca
René Perron Couvreurs Residential Roofing Contractor www.perroncouvreurs.com		Restaurants Dame Tartine Breakfast and Lunch Restaurant www.dametartine.ca
Royalty Portes Et Fenêtres Door and Window Manufacturer www.grouperoyalty.com		Salon Funéraire Kane Fetterly Funeral Services www.kanefetterly.qc.ca
Studio De Danse Imperium Dance School www.danseimperium.com

Learn more about 2025 Montréal Island Consumer Choice Award Winners HERE.

———

LAVAL’S AWARD RECIPIENTS

ABC Diesel Heavy Truck Repair www.abcdiesel.ca		Alepin Gauthier Avocats Law Firm www.alepin.com
Alpha Sécurité Et Investigation Security Services www.securalpha.com		Carrefour Dentaire 440 Dentists www.carrefourdentaire440.ca
Centre De Santé Et Beauté L’Acalmie Day Spa www.lacalmie.com		Centre De Spécialistes Dentaires Et Implantologie Dental Centre www.specialistesdentaireslaval.com
Centres Neuropsy Therapy Services www.centresneuropsy.com		Cuisine Summum Inc. Kitchen and Bathroom Renovation www.cuisinesummum.ca
Distribution Beto-Briq Inc. Building Materials www.betobriq.com		Dr. James Lee Chirugien Plastique Cosmetic Surgery www.jamesleeplasticsurgery.com
Duraclim Heating and Air Conditioning Contractor www.duraclim.com		Éco Dépot De Carreaux Céramique 440 Inc. Ceramic and Porcelain Tiles www.eco-depot.ca
EID Électrique Electrician www.eidelectrique.com		Entretien Condo Net Inc. Janitorial Service www.entretien-condo-net.com
Esthétique Éclat Beauté Aesthetic Services and Massage Therapy Clinic www.estheticiennelaval.ca		Groupe A1 Paving Contractors www.groupa1.ca
Groupe Res-Q Fire and Water Damage Restoration www.grouperesq.com		Le Génie En Herbe Lawn Maintenance www.legenieenherbe.com
Les Couvreurs Duro-Toît Residential Roofers www.lescouvreursdurotoit.com		Les Services Factotum Inc. Renovation Contractor
Maçonnerie Briquexpert Inc. Masonry www.brique-expert.com		Nettoyage Krystal Clean Housekeeping Services www.nettoyagekrystalclean.com
Nettoyeur Impeccable Éco Dry Cleaning		Nuance Design Marbre & Granit Inc. Countertops www.nuancedesign.ca
Paysagement Duguay Landscaping www.paysagementduguay.ca		Remorquage Top Speed Towing Service www.remorquage-topspeed.ca
Ryan La Haye | Planiprêt – Groupe RLH Mortgage Broker www.planipret.com		Salon Funéraire LFC Rive-Nord Funeral Services www.salonlfcrivenord.com
Théo Gosselin Pneus Et Mécanique Car Tires www.pneustheogosselin.com		Toilettage Ste-Dorothée Pet Grooming
Tutorax Tutoring www.tutorax.com		Voyage Vasco Travel Agency www.voyagevasco.com
Zabell Photo Photographer www.zabelphoto.com

Learn more about 2025 Laval Choice Award Winners HERE.

———

NORTH SHORE’S AWARD RECIPIENTS

Boulangerie Mariepain Bakery/Pastry Shop www.mariepain.com		CB Telecom Telephone system sales and service www.cbtelecom.ca
Centre De Formation 3L Driving School – Buses and Heavy Trucks www.centredeformation3l.com		Centre Dentaire Rosemère Dentist www.centredentairerosemere.com
Clôtures Frontenac Fence Manufacturer and Installer www.cloturesfrontenac.com		Drolet Électrique Electricians www.411habitation.com/electriciens/laurentides/saint-eustache-1/electriciens-saint-eustache.htm
Gestion Stéphane Légaré Residential And Commercial Real Estate www.stephanelegare.com		Gouttières Laurentides Gutters www.gouttiereslaurentides.com
Groupe Delsol Snow Removal www.groupedelsol.com		Gypsy Esthétique Beauty Institute www.gypsyesthetique.com
Institut Brabant Medical-Aesthetic Clinic www.institutbrabant.com		Intermat Doors, Stairs and Woodwork www.intermat.ca
Jardin De Ville Patio Furniture www.jardindeville.com/en/		JGA Commercial (Royal Lepage) Commercial & Industrial Real Estate Broker www.equipejeanguyayotte.com
Maison De Santé De Rosemère Multidisciplinary Care Clinic/Centre www.chirorosemere.com		Ménagez-Vous Janitorial and Housekeeping Services www.menagez-vous.ca
Nettoyage Experts Duct Cleaning www.nettoyageexperts.com		Nettoyeur De La Cité Residential and Commercial Cleaning www.nettoyeurdelacite.com
Plomberie Gariépy Plumbing www.plomberiegariepy.com		Portes Et Fenêtres Rd Doors & Windows www.portesetfenetresrd.com
RCR – Réparations Cellulaires Rapides Terrebonne Inc. Cellphone and Computer Repairs www.cellphonerepair.com/terrebonne-quebec		Remorquage Top Speed Towing Service www.remorquage-topspeed.ca
Roulottes Gauthier Recreational Vehicles www.roulottesgauthier.com		Service Randy Leclair Gutters www.servicerandyleclair.ca
St-Amour Chalut Avocats Inc. Family And Civil Law www.avocatterrebonne.ca		Twins Maçonnerie Inc. Masonry www.twinsmaconnerie.com
Voyages Fontainebleau Travel Agency www.voyagesfontainebleau.com		Webici Web Agency www.webici.ca

Learn more about 2025 North Shore Choice Award Winners HERE.

———

SOUTH SHORE’S AWARD RECIPIENTS

Aménagement Paysager Lambert Landscaping www.groupelambert.ca		ArboQuébec Tree maintenance service www.arboquebec.com
Bernard & Brassard Business Law www.bernard-brassard.com		Carrossier ProColor Ste-Julie Car Repair Shop www.procolor.com/fr-ca/atelier/sainte-julie/
Centre de Danse Espace iDance Dance School www.espaceidance.com		Clinique Vétérinaire King-George Inc Veterinary www.clivetkg.ca
Cliniques DM Aesthetic Treatments www.dermaminceur.ca		Concept Dentaire Rive-Sud Denstist www.conceptdentaire.com
Construction Enock Tanguay Inc. Contractor – Deck And Patio www.constructionenocktanguay.godaddysites.com		Éco Dépôt de Carreaux Céramique 440 Inc. Ceramic and Porcelain Tiles www.eco-depot.ca
Équipe Chamberland Residential Real Estate Broker www.equipechamberland.com		Fovéa Optométriste Optometrists And Opticians www.foveaoptometriste.com/en/
Garderie Les Petits Sportifs de St. Hubert Daycare www.garderie05.com		Géant du Web Web Agency www.geantduweb.ca
Immigration SCAT Immigration Consultant www.immigrationscat.com		Intermat Doors, Stairs And Woodwork www.intermat.ca
Jacques Cartier Pizza Pizza Restaurants www.jacquescartierpizza.com/en/		Multi-Chariots Élévateurs Inc. Forklifts And Handling Equipment www.multichariots.ca
Physio Summum Physiotherapy www.physiosummum.com		Plombier Expert Plumber www.plombierexpert.ca
Racicot et Associés Home Appraisal Services www.racicot-ass.qc.ca/index.php		Remorquage Top Speed Towing Service www.remorquage-topspeed.ca
Visam Académie Arts Martiaux Martial Arts www.visamacademie.com		Voyages & Croisières Aquamonde Travel Agency www.aquamonde.ca

Learn more about 2025 South Shore Choice Award Winners HERE.

———

About Consumer Choice Award:
Consumer Choice Award has been recognizing and promoting business excellence in North America since 1987. Its rigorous selection process ensures that only the most outstanding service providers in each category earn this prestigious recognition. Visit www.ccaward.com to learn more.

Contact Information:
Sumi Saleh
Communications Manager
ssaleh@ccaward.com

SOURCE: Consumer Choice Award

View the original press release on ACCESS Newswire